Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LivaNova PLC - Ordinary Shares (NQ:LIVN)

43.85 -0.21 (-0.48%)
Streaming Delayed Price Updated: 2:11 PM EDT, May 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about LivaNova PLC - Ordinary Shares

< Previous 1 2 Next >
LIVN Stock Earnings: LivaNova Beats EPS, Beats Revenue for Q2 2024
LIVN stock results show that LivaNova beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
LIVN Stock Earnings: LivaNova Beats EPS, Beats Revenue for Q1 2024
LIVN stock results show that LivaNova beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
Earnings Outlook For LivaNova
Via Benzinga
5 Analysts Have This to Say About LivaNova
Via Benzinga
The Latest Analyst Ratings for LivaNova
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
LivaNova PLC (NASDAQ:LIVN): An Undervalued Opportunity in Medical Technology
LivaNova PLC (NASDAQ:LIVN): An Undervalued Opportunity in Medical Technology 
Via Chartmill
In a market where value is scarce, LIVANOVA PLC (NASDAQ:LIVN) offers a refreshing opportunity with its solid fundamentals.
When you look at LIVANOVA PLC (NASDAQ:LIVN), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. 
Via Chartmill
NASDAQ:LIVN appears to be flying under the radar despite its strong fundamentals.
Discover LIVANOVA PLC, an undervalued stock. NASDAQ:LIVN showcases solid financial health and profitability while maintaining an appealing valuation. 
Via Chartmill
Earnings Scheduled For February 25, 2025
Via Benzinga
LivaNova's New Strategy Could Unlock Revenue, Profit Gains, Analyst Predicts
LivaNova gets Buy rating from Goldman Sachs analyst. $65 PT. The company appears poised for consistent revenue growth in its base business. 
Via Benzinga
Compass Minerals, Torrid Holdings, Icahn Enterprises, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
LivaNova Earnings Preview
Via Benzinga
Looking Into LivaNova's Return On Capital Employed
Via Benzinga
Recap: LivaNova Q1 Earnings
Via Benzinga
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly... 
Via Benzinga
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Walgreens To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
Via InvestorPlace
Alphabet, Boeing, Union Pacific And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones gaining around 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.